skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Long-term safety and effectiveness of sildenafil citrate in men with erectile dysfunction

(2849) Views  (473) Full article downloads

Authors: James G McMurray, Robert A Feldman, Stephen M Auerbach, Herb DeRiesthal, Neal Wilson et al

Published Date January 2007 Volume 2007:3(6) Pages 975 - 981
DOI: http://dx.doi.org/10.2147/TCRM.S

James G McMurray1, Robert A Feldman2, Stephen M Auerbach3, Herb DeRiesthal4 Neal Wilson5, On behalf of the Multicenter Study Group6

1Medical Affiliated Research Center, Huntsville, AL, USA; 2Connecticut Clinical Research Center, Waterbury, CT, USA; 3California Professional Research, Newport Beach, CA, USA; 4Pfizer Inc, New York, NY, USA; 5Formerly Pfizer Global Research and Development, Sandwich, UK, currently PPD Inc, Cambridge, UK; 6Members of the multicenter study group are listed in the appendix.

Abstract: Because sildenafil citrate is a treatment, not a cure, for erectile dysfunction (ED), many men may choose to use it for an extended period. Men with ED who had previously completed 1 of 4 double-blind trials with short-term open-label extension (combined duration, 0.9–1.2 years) were eligible for this 4-year, open-label, extension study, which assessed the safety and effectiveness of flexible doses (25, 50, and 100 mg sildenafil) used as needed. Adverse events that were serious or led to dosing changes or discontinuation (temporary or permanent) were recorded. Many of the 979 participants (mean age, 58 [range, 27–82] years; mean ED duration, 4.5 years) had concomitant hypertension (28%), diabetes (22%), or hyperlipidemia (14%). Overall, 37 (3.8%) had treatment-related adverse events (none serious) requiring dosage change or discontinuation and 62 (6.3%) discontinued because of insufficient response. At each yearly assessment, more than 94% of participants responded affirmatively to the questions: “Are you satisfied with the effect of treatment on your erections?” and “If yes, has treatment improved your ability to engage in sexual activity?” These results argue against the loss of tolerability or the development of tachyphylaxis over a prolonged period of as needed, flexible-dose sildenafil treatment of men with ED.

Keywords: sildenafil citrate, erectile dysfunction, tolerability, effectiveness








Readers of this article also read:

Differential associations between actual and expected GP practice prescribing rates for statins, ACE inhibitors, and beta-blockers: a cross-sectional study in England
Prevalence of risk factors, coronary and systemic atherosclerosis in abdominal aortic aneurysm: Comparison with high cardiovascular risk population
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Refinement of rigid-body protein–protein docking using backbone and side-chain minimization with a coarse-grained model
Functional mobility and balance in community-dwelling elderly submitted to multisensory versus strength exercises
ABO and rhesus blood group distribution in Kurds
Anesthesiologists’ perception of patients’ anxiety under regional anesthesia
Retinal nerve fiber layer thickness in recovered and persistent amblyopia
Wearing facemasks when performing lumbar punctures: a snapshot of current practice amongst trainee doctors
Corrigendum